共 97 条
[1]
Patrao NV(2016)Real-world outcomes of ranibizumab treatment for diabetic macular edema in a United Kingdom National Health Service Setting Am J Ophthalmol 172 51-57
[2]
Antao S(2009)Diabetic retinopathy and health-related quality of life Graefes Arch Clin Exp Ophthalmol 247 267-272
[3]
Egan C(2010)Burden of illness of diabetic macular edema: literature review Curr med Res Opin 26 587-1597
[4]
Omar A(2012)Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE Ophthalmology 119 789-801
[5]
Hamilton R(2011)The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema Ophthalmology 118 615-625
[6]
Davidov E(2015)Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies Ophthalmology 122 2044-2052
[7]
Breitscheidel L(2015)Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema N Engl J Med 372 1193-1203
[8]
Clouth J(2016)Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial Ophthalmology 123 1351-1359
[9]
Reips M(2017)Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1) Clin Ophthalmol 11 393-401
[10]
Happich M(2018)Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the United States Ophthalmol Retina 2 1179-1187